QUICK SEARCH:   [advanced]
Author:
Keyword(s):
Year:  Vol:  Page: 

   

 

Health Affairs, 25, no. 1 (2006): 248-255
doi: 10.1377/hlthaff.25.1.248
© 2006 by Project HOPE
 
New Online
 * Pay Cuts For Medicare Docs
 * Access To Care Woes
 * Public Coverage More Efficient
 * Empowering Consumers
This Article
* Full Text (HTML)
* Reprint (PDF)
* Online Appendix
* Submit a response to this article
* Alert me when this article is cited
* Alert me when eLetters are posted
* Alert me if a correction is posted
Services
* E-mail this article to a friend
* Similar articles in this journal
* Similar articles in ISI Web of Science
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Personal Archive
* Download to Citation Manager
*Reprints & Permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via ISI Web of Science (6)
* Citing Articles via Google Scholar
Google Scholar
* Articles by Gellad, W. F.
* Articles by Haas, J. S.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Gellad, W. F.
* Articles by Haas, J. S.
Related Collections
* Access To Care
* Business Of Health
* Consumer Issues
* Elderly
* Health Reform
* Medicare
* Pharmaceuticals
* Health Spending

DataWatch

How The New Medicare Drug Benefit Could Affect Vulnerable Populations

Walid F. Gellad, Haiden A. Huskamp, Kathryn A. Phillips and Jennifer S. Haas

This study estimates how out-of-pocket drug costs could change for vulnerable populations (racial and ethnic minorities, the near-poor, and seniors with a greater burden of chronic conditions) who qualify for the standard Medicare drug benefit. Although the new benefit might be associated with modest-to-moderate declines in out-of-pocket spending for seniors who do not qualify for subsidies, the savings might not be shared equitably and therefore might not reduce financial barriers to medication use for these populations.


Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati    What's this?


This article has been cited by other articles:


Home page
Health Aff (Millwood)Home page
M. R. Gold, S. Sofaer, and T. Siegelberg
Medicare And Cost-Effectiveness Analysis: Time To Ask The Taxpayers
Health Aff., September 1, 2007; 26(5): 1399 - 1406.
[Abstract] [Full Text] [PDF]


Home page
Health Aff (Millwood)Home page
P. Neuman, M. K. Strollo, S. Guterman, W. H. Rogers, A. Li, A. M. C. Rodday, and D. G. Safran
Medicare Prescription Drug Benefit Progress Report: Findings From A 2006 National Survey Of Seniors
Health Aff., September 1, 2007; 26(5): w630 - w643.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
S. B. Soumerai, M. Pierre-Jacques, F. Zhang, D. Ross-Degnan, A. S. Adams, J. Gurwitz, G. Adler, and D. G. Safran
Cost-related medication nonadherence among elderly and disabled medicare beneficiaries: a national survey 1 year before the medicare drug benefit.
Arch Intern Med, September 25, 2006; 166(17): 1829 - 1835.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
U. D. Patel and M. M. Davis
Falling into the Doughnut Hole: Drug Spending among Beneficiaries with End-Stage Renal Disease under Medicare Part D Plans
J. Am. Soc. Nephrol., September 1, 2006; 17(9): 2546 - 2553.
[Abstract] [Full Text] [PDF]



Home | Current Issue | Archives | Topic Collections | Search | Blog | Subscribe | Contact Us | Help

© 2001-2006 Project HOPE–The People-to-People Organization
Terms and Policies